Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,72119,740 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY Macrophages (MF) are one of the largest immune cell components of tumor lesions, where their numbers can even exceed cancer cells. MF play a key role in shaping the...

$6.85M
USD
Completed TRAINING, INDIVIDUAL
Reducing the Burden of Hepatocellular Carcinoma Among Migrant Populations: Improving prevention and outcomes through disease modeling
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2025

Project Summary Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer mortality in the United States. HCC is preventable, and it disproportionately affects migrants...

$526.9K
USD
Completed OTHER RESEARCH-RELATED
Investigation of the Carcinogenic Effects of Bactericidal Antibiotics in the Gut
NATIONAL CANCER INSTITUTE Harvard University United States 2021 – 2023

Project Summary/Abstract Colitis-associated cancer (CAC) refers to the pathological transition from inflammatory bowel disease (IBD) to colorectal cancer (CRC). Burgeoning evidence...

$967K
USD
Completed TRAINING, INDIVIDUAL
Development of a tumor-activated IL12 prodrug to treat solid tumors
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary/Abstract: Despite recent advances in cancer immunotherapy, solid tumors remain largely refractory to treatment due to disruption of immune homeostasis by the tumor...

$467.5K
USD
Completed NON-SBIR/STTR RPGS
Peer Coaching for Physical Activity Promotion among Breast Cancer Survivors: Adapting an Efficacious Intervention to Prepare for Implementation
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2021 – 2025

Interventions promoting physical activity among cancer survivors improve their functioning, reduce fatigue and offer other benefits in cancer recovery and risk reduction for future...

$3.34M
USD
Completed NON-SBIR/STTR RPGS
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY Triple-negative breast cancer (TNBC) is the deadliest and 2nd most common subtype of breast cancer in the United States. Although promising new drugs based on PARP...

$5.05M
USD
Completed TRAINING, INDIVIDUAL
Investigating TLR-agonist adjuvancy in STING-activating nanoparticle cancer vaccines
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2023

Project Summary/Abstract Therapeutic vaccination against melanoma has yet to realize its clinical potential. Several phase III clinical trials assessing efficacy of vaccination aga...

$320.7K
USD
Completed NON-SBIR/STTR RPGS
Overcoming ibrutinib resistance in mantle cell lymphoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

Project Abstract Ibrutinib, a covalent inhibitor of Bruton tyrosine kinase (BTK) and similar inhibitors of B-cell receptor (BCR)- associated kinases are shifting the therapeutic la...

$4.41M
USD
Completed NON-SBIR/STTR RPGS
Mitochondrial lateral transfer during metastasis
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2026

Project Summary Macrophages play paradoxical roles in cancer: They can be tumoricidal, but in many cancers, macrophages promote metastasis. There has been growing evidence that mac...

$3.42M
USD
Completed NON-SBIR/STTR RPGS
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDAC) is one of the most chemorefractory cancers among solid tumors. Even with the most effective chemotherapy (i.e., FOLFIRINOX), only 30% of PDA...

$4.6M
USD
Completed NON-SBIR/STTR RPGS
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

Project Summary The median survival for metastatic melanoma is approximately 8–16 months, and few therapies offer a significant improvement in overall survival. However, immunother...

$6.06M
USD
Completed OTHER RESEARCH-RELATED
Elucidating USP16 function and probing its DUB activity in Down syndrome leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2025

Project Summary / Abstract Myelodysplastic syndromes (MDS) are heterogeneous clonal hematopoietic stem and progenitor cell (HSPC) disorders with frequent transformation to acute my...

$869.3K
USD
Completed NON-SBIR/STTR RPGS
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2026

Project Summary While activated T cells cross the blood-brain barrier (BBB), immunotherapy has yet to be harnessed for targeted therapy due to GBM’s heterogeneity and immunosuppres...

$4.35M
USD
Completed SBIR-STTR RPGS
Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia
NATIONAL CANCER INSTITUTE Cooler Heads Care Inc United States 2021 – 2025

PROJECT SUMMARY—Approximately two-thirds of patients undergoing cancer treatment experience hair loss from chemotherapy-induced alopecia (CIA). Patients say CIA is one of the most...

$10.37M
USD
Completed OTHER RESEARCH-RELATED
The ontogeny and function of CD8 T cells in lung cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Targeting the immune system to destroy cancer cells using immunotherapy has rapidly emerged as a promising avenue for treating cancer, and has resulted in...

$2.08M
USD
Completed NON-SBIR/STTR RPGS
Discovering the role of YES1 in triple negative breast cancer
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT SRC Family Kinases (SFKs) are a group of 9 non-receptor tyrosine kinases that mediate the effects of many extracellular and intracellular signaling pathway...

$313.2K
USD
Completed OTHER RESEARCH-RELATED
The ontogeny and function of CD8 T cells in lung cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Targeting the immune system to destroy cancer cells using immunotherapy has rapidly emerged as a promising avenue for treating cancer, and has resulted in...

$2.08M
USD
Completed NON-SBIR/STTR RPGS
Overcoming ibrutinib resistance in mantle cell lymphoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

Project Abstract Ibrutinib, a covalent inhibitor of Bruton tyrosine kinase (BTK) and similar inhibitors of B-cell receptor (BCR)- associated kinases are shifting the therapeutic la...

$4.28M
USD
Active TRAINING, INDIVIDUAL
The effect of epigenetic DNA methylation on the progression of HPV-associated precancerous cervical lesions
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY Reducing morbidity and mortality due to invasive cervical cancer (ICC) is a global health priority, which can be accomplished in part by improving the timely detect...

$537.9K
USD
Completed OTHER RESEARCH-RELATED
Improving sleep in gynecologic cancer survivors
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

PROJECT SUMMARY Sleep disturbance is one of the primary complaints of gynecologic cancer survivors, with more than 80% of survivors reporting sleep difficulties. Sleep disturbance...

$1.73M
USD